OHR Pharmaceutical Inc Stock Nasdaq
Equities
US67778H3093
Biotechnology & Medical Research
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 1.42M 1.94M |
---|---|---|---|---|---|
Net income 2023 * | -12M -16.41M | Net income 2024 * | - | EV / Sales 2023 * | - |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-0.05
x | P/E ratio 2024 * |
-
| Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 86.62% |
Latest transcript on OHR Pharmaceutical Inc
Managers | Title | Age | Since |
---|---|---|---|
Todd Branning
CEO | Chief Executive Officer | 54 | 22-01-09 |
Dani Stoltzfus
PRN | Corporate Officer/Principal | - | - |
Ron Sarkar
PRN | Corporate Officer/Principal | - | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dov Goldstein
CHM | Chairman | 56 | 19-07-11 |
Eric Richman
BRD | Director/Board Member | 63 | 19-07-11 |
Gerald McDougall
BRD | Director/Board Member | 57 | 21-05-10 |
1st Jan change | Capi. | |
---|---|---|
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+46.68% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |